Study Feasibility

Video transcript: Improving diversity in clinical trials. It's not just the right thing to do. It's necessary for improving health equity. Too often clinical trial participation is too narrowly focused, reducing the quality of outcomes and limiting some therapy's ability to help humanity as a whole. But what if a key to making clinical research more representative was deeper data? What if doing the right thing were actually the same? With Medidata AI Intelligent Trials, they are. With it, you get actionable insights during a trial's planning stage. So you can make confident selection decisions that consider both site level operational performance and the site's ability to recruit diverse patient populations for trials that enroll quickly and are more representative of diverse populations. Offering standardized and analysis ready demographic and operational data in a study's planning stages, you can optimize both operational and diversity performance from the very start. So diversity planning can easily become a cornerstone of your feasibility planning. Benefit of all people.